Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese PAC: Telbivudine in Chronic Hepatitis B
NCT00781105Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2008
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Started Aug 2008; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00781105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781105.